Letter to the Editor, Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans

Biopharm Drug Dispos. 2017 Oct;38(7):443-444. doi: 10.1002/bdd.2079. Epub 2017 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / antagonists & inhibitors*
  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / metabolism
  • Antihypertensive Agents / pharmacokinetics
  • Drug Interactions / physiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics
  • Intestinal Absorption / drug effects
  • Intestinal Absorption / physiology*
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Rosuvastatin Calcium / pharmacokinetics*
  • Telmisartan / pharmacokinetics*

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Neoplasm Proteins
  • Rosuvastatin Calcium
  • Telmisartan